<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02399358</url>
  </required_header>
  <id_info>
    <org_study_id>2439</org_study_id>
    <nct_id>NCT02399358</nct_id>
  </id_info>
  <brief_title>Factors Associated With Hyponatremia Induced by High-dose Cyclophosphamide</brief_title>
  <official_title>Factors Associated With Hyponatremia Induced by High-dose Cyclophosphamide: Prospective Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Diego Hernan Giunta, MD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Italiano de Buenos Aires</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospoctive cohort of high-dose cyclophosphamide exposed patients. With active estandardize
      screening of hyponatremia development in the follow up period.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Primary objectives

        1. To identify the factors associated with the development of hyponatremia in patients
           receiving high-dose cyclophosphamide (2.5 grams or more).

        2. Generate and validate a predictive score of developing hyponatremia high-dose
           cyclophosphamide.

        3. To estimate the incidence of hyponatremia in patients undergoing high-dose
           cyclophosphamide.

      Study design. Observational prospective cohort study of Patients after infusion of high-dose
      cyclophosphamide. Follow up period will be from cyclophosphamide infusion until one month
      after hospital discharge.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>December 2015</start_date>
  <completion_date type="Anticipated">November 2017</completion_date>
  <primary_completion_date type="Anticipated">June 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Hyponatremia</measure>
    <time_frame>Between 6 and 8 hours after the infusion of cyclophosphamide is performed.</time_frame>
    <description>Hyponatremia, measured as any value sodium after infusion and defined as positive if sodium less than 135 mEq / l (Yes / No, dichotomous categorical variable). For the incidence of hyponatremia is only included in the calculation hionatremia patients with normal sodium before infusion.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Hyponatremia</condition>
  <arm_group>
    <arm_group_label>High-dose Cyclophosphamide</arm_group_label>
    <description>Patients requiring infusion of high-dose cyclophosphamide in the period 2015-2017 will be included. After informed consent, patients will de follow up from the infusion of cyclophosphamide to 30 days after hospital discharge.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients (Over 18 years) admitted for high-dose cyclophosphamide.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients (over 18 years) who were admitted to the Hematology / Oncology and
             Medical Clinic Hospital Italiano de Buenos Aires infusion of high-dose
             cyclophosphamide for conducting MSCH prior BMT, GATLA and HyperCVAD in the period
             2015-2017.

        Exclusion Criteria:

          -  Refusal to participate or to the process of informed consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fernando Warley, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Italiano de Buenos Aires</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Belen Bonella, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Italiano de Buenos Aires</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Victoria Otero, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Italiano de Buenos Aires</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bruno L Ferreyro, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Italiano de Buenos Aires</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Fernando Warley, MD</last_name>
    <phone>+54 9 11 61541958</phone>
    <email>fernando.warley@hospitalitaliano.org.ar</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Belen Bonella, MD</last_name>
    <phone>+54 9 11 21620279</phone>
    <email>maria.bonella@hospitalitaliano.org.ar</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital Italiano de Buenos Aires, Peron 4190</name>
      <address>
        <city>Ciudad Autonoma de Buenos Aires</city>
        <state>Capital Federal</state>
        <zip>C1199ABB</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Diego H Giunta, MD</last_name>
      <phone>+54 9 11 5825-6489</phone>
      <email>diego.giunta@hospitalitaliano.org.ar</email>
    </contact>
    <contact_backup>
      <last_name>Cristina M Elizondo, MD</last_name>
      <phone>+54 9 11 5745-8048</phone>
      <email>cristina.elizondo@hospitalitaliano.org.ar</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Argentina</country>
  </location_countries>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 22, 2015</study_first_submitted>
  <study_first_submitted_qc>March 25, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 26, 2015</study_first_posted>
  <last_update_submitted>December 16, 2015</last_update_submitted>
  <last_update_submitted_qc>December 16, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 17, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Italiano de Buenos Aires</investigator_affiliation>
    <investigator_full_name>Diego Hernan Giunta, MD</investigator_full_name>
    <investigator_title>Investigator</investigator_title>
  </responsible_party>
  <keyword>Drug induced Hyponatremia</keyword>
  <keyword>Cyclophosphamide</keyword>
  <keyword>Hyponatremia</keyword>
  <keyword>Cyclophosphamide induced Hyponatremia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyponatremia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cyclophosphamide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

